Predni-Sediv en es it fr

Predni-Sediv Brand names, Predni-Sediv Analogs

Predni-Sediv Brand Names Mixture

  • No information avaliable

Predni-Sediv Chemical_Formula


Predni-Sediv RX_link

Predni-Sediv fda sheet

Predni-Sediv FDA

Predni-Sediv msds (material safety sheet)

Predni-Sediv Synthesis Reference

No information avaliable

Predni-Sediv Molecular Weight

387.711 g/mol

Predni-Sediv Melting Point

No information avaliable

Predni-Sediv H2O Solubility

No information avaliable

Predni-Sediv State


Predni-Sediv LogP


Predni-Sediv Dosage Forms

Cream; Ointment; Suppository (each applicator-full provides approximately 4.6 grams of ointment containing 300 mg of tioconazole)

Predni-Sediv Indication

For the local treatment of vulvovaginal candidiasis (moniliasis).

Predni-Sediv Pharmacology

Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against Candida albicans, other species of the genus Candida, and against Torulopsis glabrata. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. This drug is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.

Predni-Sediv Absorption

Systemic absorption following a single intravaginal application of tioconazole in nonpregnant patients is negligible.

Predni-Sediv side effects and Toxicity

Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning,

Predni-Sediv Patient Information

Predni-Sediv Organisms Affected

Yeast and other fungi